Temporary Stool-Diverting device aims to prevent dangerous leaks after colon surgery
NCT ID NCT03423485
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This study tests a temporary device called CG-100 that is placed inside the bowel after colorectal surgery to divert stool away from the surgical connection (anastomosis). The goal is to see if the device can create a leak-proof seal and reduce the risk of anastomotic leakage, a serious complication. About 30 adults scheduled for elective colorectal surgery will receive the device during their operation and be followed for about 10 days.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- CG-100 Intraluminal Bypass Device
- What this could lead to
- If successful, this device could reduce the risk of dangerous leaks at the surgical connection after colorectal surgery, potentially improving recovery and reducing complications.
- What could go wrong
- This is a small, early-stage study with only 30 participants, so results may not apply to all patients. The device may fail to seal properly or cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Jan 2018
- Finished
-
Dec 2018
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
22 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. The patient is willing to comply with protocol-specified follow-up evaluations 2. Patient 22-75 years of age at screening 3. The patient is scheduled to undergo an elective colorectal surgery (open, laparoscopic, or robotic) which will require the creation of an anastomosis, maximally 20 cm proximal from the anal verge 4. The patient or legally authorized representative, has been informed of the nature of the study, agrees to its provisions and has provided written informed consent, approved by the appropriate Medical Ethics Committee (EC) or Institutional Review Board (IRB). Exclusion Criteria: Preoperative 1. Pregnant or nursing female subjects. Female subjects of child-bearing potential must have a negative pregnancy test done within 7 days prior to surgical procedure per site standard test. 2. Patient surgical treatment is acute (not elective) 3. Patient has local or systemic infection at the time of intervention (e.g., peritonitis) 4. Major surgical or interventional procedures within 30 days prior to this study or planned surgical or interventional procedures within 30 days of entry into this study 5. Patients with ASA classification \> 3 6. Albumin \< 30 g/liter 7. Patient has a diagnosis of bowel obstruction, bowel strangulation, peritonitis, bowel perforation, ischemic bowel, carcinomatosis or extensively spread inflammatory bowel disease 8. BMI ≥ 40 9. Subject is going through another surgical procedure (other than ileostomy or adhesiolysis) during the surgery. 10. Patient is participating in another clinical trial within 30 days of screening 11. Patient has been taking regular steroid medication in the last 6 months. 12. Patient has contraindications to general anesthesia 13. Patient has preexisting sphincter problems 14. Patient has evidence of extensive local disease in the pelvis 15. Any condition which in the opinion of the investigator may jeopardize the patient's safe participation Intraoperative (prior to device deployment) 16. Anastomosis is located more than 20 cm from the anal verge 17. Internal diameter lumen of the colon is smaller than 25 mm or larger than 34 mm 18. Blood loss (\> 500 cc) 19. Anastomosis was not performed for any reason other than consequences as a result of use of the study device -
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Colorectal surgery are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHUV, University Hospital Vaudois
Lausanne, Switzerland
-
Carmel Medical Center
Haifa, Israel
-
Hospital Beaujon
Paris, Clichy, 92110, France
-
Soroka Medical Center
Beersheba, 85025, Israel
-
University Hospital of Hamburg
Hamburg, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Prostate drug tested to stop urinary problems after rectal surgery
- Can surgery pain be managed without opioids?
- A balloon tube that could spare patients a stoma after bowel surgery
- Gut instinct: listening to bowel sounds may reveal hidden clues about surgical recovery
- Could skipping bowel prep before colon surgery be just as safe?
- New Stent-Vacuum combo may fix Post-Surgery leaks without extra operations